Home > Insider Trading > Filing (0001225208-11-012576)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
901219	Human Genome Sciences Inc	HGSI	Biological Products, (No Disgnostic Substances) (2836)	223178468

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1332456	Barry Labinger	14200 Shady Grove Road Rockville MD 20850	Exec Vp & Cco	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2011-04-28	28,113	$0.52	28,113	No	4	M	Direct
Common Stock	Acquisiton	2011-04-28	11,853	$4.92	39,966	No	4	M	Direct
Common Stock	Disposition	2011-04-28	11,853	$30.00	28,113	No	4	S	Direct
Common Stock	Disposition	2011-04-28	28,113	$30.00	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option - Right to Buy	Disposition	2011-04-28	11,853	$0.00	11,853	$4.92
Common Stock	Employee Stock Option - Right to Buy	Disposition	2011-04-28	28,113	$0.00	28,113	$0.52

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
59,018		2018-03-10	No	4	M	Direct
75,020		2019-03-10	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and Charles Schwab effective March 18, 2011.
One-eighth of the 150,000 options granted on March 10, 2008, vested on the six-month anniversary date (September, 2008) and the remaining options granted vested and continue to vest monthly on a ratable basis for the next 42 months commencing on October 10, 2008.
One-eighth of the 150,000 options granted on March 10, 2009, vested on the six-month anniversary date (September, 2009) and the remaining options granted vested and continue to vest monthly on a ratable basis for the next 42 months commencing on October 10, 2009.